These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1153475)
1. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 1: flow properties and water sorption. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Mar; 30(3):181-5. PubMed ID: 1153475 [TBL] [Abstract][Full Text] [Related]
2. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 2: Comparative self-binding properties. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Apr; 30(4):236-8. PubMed ID: 1153489 [TBL] [Abstract][Full Text] [Related]
3. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 3: Effect of diluents. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Jun; 30(6):373-6. PubMed ID: 1161787 [TBL] [Abstract][Full Text] [Related]
4. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 6: Effect of drug. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Jul; 30(7):463-5. PubMed ID: 1178764 [TBL] [Abstract][Full Text] [Related]
5. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 4: Effect of disintegrants. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Jun; 30(6):377-82. PubMed ID: 1161788 [TBL] [Abstract][Full Text] [Related]
6. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 5: Effects of lubricants and flow conditions. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Jun; 30(6):378-82. PubMed ID: 169527 [TBL] [Abstract][Full Text] [Related]
7. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets. Asker AF; Saied KM; Abdel-Khalek MM Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between flow properties of vehicles for direct compression and weight uniformity of pills made on a rotary tabletting machine]. Delattre L; Gillard J; Jaminet F; Roland M J Pharm Belg; 1975; 30(1):23-38. PubMed ID: 1151604 [No Abstract] [Full Text] [Related]
9. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties. Herting MG; Kleinebudde P Int J Pharm; 2007 Jun; 338(1-2):110-8. PubMed ID: 17324537 [TBL] [Abstract][Full Text] [Related]
10. Fast-melting tablets based on highly plastic granules. Fu Y; Jeong SH; Park K J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059 [TBL] [Abstract][Full Text] [Related]
11. A study of the properties of tablets from coprocessed dry binders composed of alpha-lactose monohydrate and different types of cellulose. Muzíková J; Zvolánková J Ceska Slov Farm; 2007 Dec; 56(6):269-75. PubMed ID: 18257417 [TBL] [Abstract][Full Text] [Related]
12. [The effect of incorporation technics of water soluble macromolecular binders on the properties of fluidized-bed dried granules]. Richter M; Rahn HW; Voigt R Pharmazie; 1989 Jan; 44(1):43-6. PubMed ID: 2727029 [TBL] [Abstract][Full Text] [Related]
13. Development of an oral rutin nanocrystal formulation. Mauludin R; Müller RH; Keck CM Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097 [TBL] [Abstract][Full Text] [Related]
14. [The dry binders, Vivapur 102, Vivapur 12 and the effect of magnesium stearate on the strength of tablets containing these substances]. Muzíková J; Horácek J Ceska Slov Farm; 2003 Jul; 52(4):176-80. PubMed ID: 12924068 [TBL] [Abstract][Full Text] [Related]
15. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches. Odeku OA; Schmid W; Picker-Freyer KM Eur J Pharm Biopharm; 2008 Sep; 70(1):357-71. PubMed ID: 18562187 [TBL] [Abstract][Full Text] [Related]
16. Potential of carnuba wax in ameliorating brittle fracture during tableting. Uhumwangho MU; Okor RS; Adogah JT Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422 [TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of dried yeast tablets using different techniques. Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410 [TBL] [Abstract][Full Text] [Related]
18. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting. Schmid W; Picker-Freyer KM Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337 [TBL] [Abstract][Full Text] [Related]
19. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract]. Zgoda MM; Nachajski MJ; Kołodziejczyk MK Polim Med; 2009; 39(1):17-30. PubMed ID: 19580170 [TBL] [Abstract][Full Text] [Related]
20. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example. Sun CC Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]